Johnson ES - Search Results

1

An economic evaluation of a laboratory monitoring program for renin-angiotensin system agents.

Smith DH, Raebel MA, Chan KA, Johnson ES, Petrik AF, Weiss JR, Yang X, Feldstein A. Smith DH, et al. Among authors: johnson es. Med Decis Making. 2011 Mar-Apr;31(2):315-24. doi: 10.1177/0272989X10379918. Med Decis Making. 2011. PMID: 21393563

2

Managing the burden of chronic kidney disease.

Thorp ML, Eastman L, Smith DH, Johnson ES. Thorp ML, et al. Among authors: johnson es. Dis Manag. 2006 Apr;9(2):115-21. doi: 10.1089/dis.2006.9.115. Dis Manag. 2006. PMID: 16620197 Review.

3

Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease.

DeVille J, Thorp ML, Tobin L, Gray E, Johnson ES, Smith DH. DeVille J, et al. Among authors: johnson es. Nephrology (Carlton). 2006 Dec;11(6):555-9. doi: 10.1111/j.1440-1797.2006.00698.x. Nephrology (Carlton). 2006. PMID: 17199797 Clinical Trial.

4

Predicting renal replacement therapy and mortality in CKD.

Johnson ES, Thorp ML, Yang X, Charansonney OL, Smith DH. Johnson ES, et al. Am J Kidney Dis. 2007 Oct;50(4):559-65. doi: 10.1053/j.ajkd.2007.07.006. Am J Kidney Dis. 2007. PMID: 17900455

5

Predicting the risk of dialysis and transplant among patients with CKD: a retrospective cohort study.

Johnson ES, Thorp ML, Platt RW, Smith DH. Johnson ES, et al. Am J Kidney Dis. 2008 Oct;52(4):653-60. doi: 10.1053/j.ajkd.2008.04.026. Epub 2008 Jun 30. Am J Kidney Dis. 2008. PMID: 18585833

6

Secular trends in kidney disease: is the decreased incidence of renal replacement therapy due to a decrease in chronic kidney disease incidence?

Thorp ML, Weinstein JR, Johnson ES, Yang X, Smith DH. Thorp ML, et al. Among authors: johnson es. Clin Nephrol. 2008 Sep;70(3):187-93. doi: 10.5414/cnp70187. Clin Nephrol. 2008. PMID: 18793559

7

Lower visual acuity predicts worse utility values among patients with type 2 diabetes.

Smith DH, Johnson ES, Russell A, Hazlehurst B, Muraki C, Nichols GA, Oglesby A, Betz-Brown J. Smith DH, et al. Among authors: johnson es. Qual Life Res. 2008 Dec;17(10):1277-84. doi: 10.1007/s11136-008-9399-1. Epub 2008 Oct 30. Qual Life Res. 2008. PMID: 18972222

8

Effect of anaemia on mortality, cardiovascular hospitalizations and end-stage renal disease among patients with chronic kidney disease.

Thorp ML, Johnson ES, Yang X, Petrik AF, Platt R, Smith DH. Thorp ML, et al. Among authors: johnson es. Nephrology (Carlton). 2009 Apr;14(2):240-6. doi: 10.1111/j.1440-1797.2008.01065.x. Nephrology (Carlton). 2009. PMID: 19207866

9

Hyperparathyroidism in chronic kidney disease: a retrospective cohort study of costs and outcomes.

Smith DH, Johnson ES, Thorp ML, Yang X, Neil N. Smith DH, et al. Among authors: johnson es. J Bone Miner Metab. 2009;27(3):287-94. doi: 10.1007/s00774-009-0048-8. Epub 2009 Mar 31. J Bone Miner Metab. 2009. PMID: 19333685

10

Comparison of renal replacement therapy and mortality using 1 versus 2 estimated glomerular filtration rates.

Thorp ML, Weinstein J, DeVille J, Johnson ES, Petrik A, Yang X, Smith DH. Thorp ML, et al. Among authors: johnson es. Popul Health Manag. 2009 Jun;12(3):149-55. doi: 10.1089/pop.2008.0024. Popul Health Manag. 2009. PMID: 19534579

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

369 results

Search Page